Loading organizations...
Key people at Vital Venture Capital.
Vital Venture Capital was founded in 2007 by Norman L. Norris (Principal and co-founder).
Vital Venture Capital is a venture capital firm specializing in private investments within industries where its principals possess deep operational knowledge and extensive experience. The firm invests across both early-stage startups and later-stage businesses, prioritizing those with a clear path to revenue generation and sustainable growth. They differentiate by actively nurturing portfolio companies, providing strategic insight, practical knowledge, and direct experience in technology, software, and intellectual property.
The firm's foundation is built upon the collective expertise of its principal investors, including A. Craig Asher, Nathaniel C. Brinn, and Norman L. Norris, each with over 25 years of experience. Asher brings a background in developing and scaling software companies, Brinn has a successful track record in private equity investments and managing growth companies, while Norris offers significant experience in intellectual property law and venture investments. Their combined insight from successfully starting, growing, and selling companies informs their investment philosophy and hands-on approach.
Vital Venture Capital partners with businesses led by forthright visionaries who demonstrate operational thriftiness and a focus on achieving exit value. The firm’s vision is to foster positive, innovative, and results-driven environments, applying a patient and value-oriented investment approach. By leveraging its principals' proven track records and active involvement, Vital Venture Capital aims to drive significant growth and achieve successful outcomes for its portfolio companies.
Vital Venture Capital was founded in 2007 by Norman L. Norris (Principal and co-founder).
Vital Venture Capital has 2 tracked investments across 1 company. The latest tracked deal is $7.5M Series A in RubrYc Therapeutics in August 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 25, 2021 | RubrYc Therapeutics | $7.5M Series A | TOM Isett | Hayan Health Networks, Paladin Capital Group, Third Point Ventures |
| Apr 11, 2018 | RubrYc Therapeutics | $10.0M Series A | Third Point Ventures | Paladin Capital Group |
Key people at Vital Venture Capital.